{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:12:39Z","timestamp":1779250359533,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T00:00:00Z","timestamp":1771718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016304","name":"Medtronic Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ahj.2026.107387","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:48:22Z","timestamp":1771865302000},"page":"107387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and rationale of the COMPARE-TAVI 2 trial: An all-comers head-to-head comparison of Evolut FX+ and Sapien 3 Ultra Resilia transcatheter heart valves"],"prefix":"10.1016","volume":"297","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1014-5559","authenticated-orcid":false,"given":"Troels","family":"Thim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"Niemel\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashkan","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko","family":"Jalanko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko","family":"Savontaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pertti","family":"J\u00e4\u00e4skel\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hensey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekka Vibjerg","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjarne Linde","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Alcaraz","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik \u00d8lholm","family":"Vase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evald H\u00f8j","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Juhl","family":"Terkelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107387_bib0001","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ahj.2024.05.003","article-title":"Randomized comparison of TAVI valves: the compare-TAVI trial","volume":"274","author":"Terkelsen","year":"2024","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107387_bib0002","doi-asserted-by":"crossref","unstructured":"Terkelsen C.J., Freeman P., Dahl J.S., et al. SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, noninferiority trial. The Lancet. doi:10.1016\/S0140-6736(25)00106-0","DOI":"10.1016\/S0140-6736(25)00106-0"},{"issue":"19","key":"10.1016\/j.ahj.2026.107387_bib0003","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"42","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.ahj.2026.107387_bib0004","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized Bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"35","key":"10.1016\/j.ahj.2026.107387_bib0005","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.ahj.2026.107387_bib0006","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ahj.2026.107387_bib0007","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ahj.2026.107387_bib0008","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ahj.2026.107387_bib0009","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ahj.2026.107387_bib0010","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.jacc.2014.02.556","article-title":"Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery","volume":"63","author":"Popma","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.ahj.2026.107387_bib0011","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis","volume":"370","author":"Adams","year":"2014","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ahj.2026.107387_bib0012","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ahj.2026.107387_bib0013","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107387_bib0014","first-page":"Y37","article-title":"TAVI device selection: time for a patient-specific approach","volume":"12","author":"Lee","year":"2016","journal-title":"EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2026.107387_bib0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tcm.2021.10.002","article-title":"The selection of transcatheter heart valves in transcatheter aortic valve replacement","volume":"32","author":"Tugaoen","year":"2022","journal-title":"Trends Cardiovasc Med"},{"issue":"20","key":"10.1016\/j.ahj.2026.107387_bib0016","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/eurheartj\/ehaa036","article-title":"Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial","volume":"41","author":"Thiele","year":"2020","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.ahj.2026.107387_bib0017","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1001\/jama.2014.3316","article-title":"Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial","volume":"311","author":"Abdel-Wahab","year":"2014","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ahj.2026.107387_bib0018","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jcin.2019.12.026","article-title":"5-Year outcomes after TAVR with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial","volume":"13","author":"Abdel-Wahab","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"10445","key":"10.1016\/j.ahj.2026.107387_bib0019","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/S0140-6736(24)00821-3","article-title":"LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial","volume":"403","author":"Baumbach","year":"2024","journal-title":"The Lancet"},{"issue":"21","key":"10.1016\/j.ahj.2026.107387_bib0020","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa2312573","article-title":"Self-expanding or balloon-expandable TAVR in patients with a small aortic annulus","volume":"390","author":"Herrmann","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ahj.2026.107387_bib0021","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/CIRCULATIONAHA.119.043785","article-title":"Balloon-expandable versus self-expanding transcatheter aortic valve replacement: a propensity-matched comparison from the FRANCE-TAVI registry","volume":"141","author":"Van Belle","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahj.2026.107387_bib0022","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1161\/CIRCULATIONAHA.119.043971","article-title":"Impact of Sapien 3 balloon-expandable versus Evolut R self-expandable transcatheter aortic valve implantation in patients with aortic stenosis: data from a nationwide analysis","volume":"141","author":"Deharo","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahj.2026.107387_bib0023","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.119.044449","article-title":"Transcatheter heart valve design and mortality: truth or dare?","volume":"141","author":"Abdel-Wahab","year":"2020","journal-title":"Circulation"},{"issue":"10209","key":"10.1016\/j.ahj.2026.107387_bib0024","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0140-6736(19)32220-2","article-title":"Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial","volume":"394","author":"Lanz","year":"2019","journal-title":"The Lancet"},{"issue":"25","key":"10.1016\/j.ahj.2026.107387_bib0025","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1161\/CIRCULATIONAHA.120.051547","article-title":"Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis","volume":"142","author":"Tamburino","year":"2020","journal-title":"Circulation"},{"issue":"10494","key":"10.1016\/j.ahj.2026.107387_bib0026","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(25)00319-8","article-title":"ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial","volume":"405","author":"Makkar","year":"2025","journal-title":"Lancet Lond Engl"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326000499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326000499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:02:35Z","timestamp":1779249755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870326000499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S0002870326000499"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107387","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and rationale of the COMPARE-TAVI 2 trial: An all-comers head-to-head comparison of Evolut FX+ and Sapien 3 Ultra Resilia transcatheter heart valves","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107387"}}